Category Archives: Nat Med

An unexpected role for bile acid synthesis in adaptation to low temperature.






Related Articles
An unexpected role for bile acid synthesis in adaptation to low temperature.
Nat Med. 2017 Jul 11;23(7):800-802
Authors: Kuipers F, Groen AK
PMID: 28697185 [PubMed – in process]

Continue reading

Posted in Nat Med | Tagged , | Leave a comment

FXR: the key to benefits in bariatric surgery?






Related Articles
FXR: the key to benefits in bariatric surgery?
Nat Med. 2014 Apr;20(4):337-8
Authors: Kuipers F, Groen AK
PMID: 24710375 [PubMed – indexed for MEDLINE]

Continue reading






Posted in Nat Med | Tagged , | Leave a comment

Encapsulate this: the do’s and don’ts.






Related Articles
Encapsulate this: the do’s and don’ts.
Nat Med. 2014 Mar;20(3):233
Authors: Orive G, Emerich D, De Vos P
PMID: 24603789 [PubMed – indexed for MEDLINE]

Continue reading






Posted in Nat Med | Tagged , | Leave a comment

Encapsulate this: the do’s and don’ts.






Related Articles

Encapsulate this: the do’s and don’ts.

Nat Med. 2014 Mar;20(3):233

Authors: Orive G, Emerich D, De Vos P

PMID: 24603789 [PubMed -…

Continue reading






Posted in Nat Med | Tagged | Leave a comment

2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis.






Related Articles
2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis.
Nat Med. 2014 Feb;20(2):215-9
Authors: Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, Taha… Continue reading






Posted in Nat Med | Tagged , | Leave a comment

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.






Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.

Nat Med. 2011 Sep 18;

Authors: van Dam GM, Themelis G,…

Continue reading






Posted in Nat Med | Tagged | Comments Off on Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.